Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
Open Access
- 24 November 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (1) , 1083-1091
Abstract
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in japanKeywords
This publication has 49 references indexed in Scilit:
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEuropean Journal of Cancer, 2011
- Cancer Cachexia: Mechanisms and Clinical ImplicationsGastroenterology Research and Practice, 2011
- The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyBritish Journal of Cancer, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Cancer-related inflammationNature, 2008
- Clinical and immunohistologic typing of salivary duct carcinomaCancer, 2005
- Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourselfNature Clinical Practice Oncology, 2005
- Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumourJournal of Clinical Pathology, 2003
- Salivary duct carcinomaOral Surgery, Oral Medicine, Oral Pathology, 1994